Insider Shake-Up at Kestra Medical Technologies Sparks Investor Buzz
TipRanks (Thu, 1-Oct 10:02 PM ET)
Globe Newswire (Thu, 1-Oct 6:00 AM ET)
CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors
Business Wire (Thu, 24-Sep 3:49 AM ET)
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Globe Newswire (Mon, 14-Sep 4:01 PM ET)
Kestra Names Daniel Finney Vice President of Research & Development
Globe Newswire (Thu, 10-Sep 6:00 AM ET)
Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
Globe Newswire (Mon, 31-Aug 4:01 PM ET)
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
Globe Newswire (Wed, 26-Aug 6:00 AM ET)
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
Globe Newswire (Tue, 14-Jul 4:05 PM ET)
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Globe Newswire (Tue, 14-Jul 4:01 PM ET)
Market Chameleon (Wed, 3-Dec 5:34 AM ET)
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Kestra Medical Techs trades on the NASDAQ stock market under the symbol KMTS.
As of October 2, 2026, KMTS stock price climbed to $27.43 with 236,173 million shares trading.
KMTS has a beta of 1.53, meaning it tends to be more sensitive to market movements. KMTS has a correlation of 0.08 to the broad based SPY ETF.
KMTS has a market cap of $1.63 billion. This is considered a Small Cap stock.
Last quarter Kestra Medical Techs reported $31 million in Revenue and -$.75 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.13.
The top ETF exchange traded funds that KMTS belongs to (by Net Assets): VTI, IWM, IWO, FYC, VXF.
KMTS has underperformed the market in the last year with a return of +12.6%, while the SPY ETF gained +16.1%. In the last 3 month period, KMTS fell short of the market, returning +1.7%, while SPY returned +3.6%. However, in the most recent 2 weeks KMTS has outperformed the stock market by returning +12.3%, while SPY returned +1.0%.
KMTS support price is $25.95 and resistance is $28.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMTS shares will trade within this expected range on the day.
